文献速递关节外科

髌股关节置换术治疗孤立性髌股骨关节炎短期比全膝关节置换术更便宜且更有效:基于随机试验的成本效果分析

Patellofemoral arthroplasty is cheaper and more effective in the short term than total knee arthroplasty for isolated patellofemoral osteoarthritis: cost-effectiveness analysis based on a randomized trial.
PubMed 文献 · Bone Joint J · 2020-01-01

基于一项盲法随机临床试验的前瞻性健康结局与资源使用数据,纳入100例孤立性髌股骨关节炎患者,比较髌股关节置换术(PFA)与全膝关节置换术(TKA)的成本效果。结果显示PFA组12个月EQ-5D增益0.056(95%CI 0.01至0.10),增量成本为负€328(95%CI 836至180),PFA以更优且更便宜的结果占优TKA;在€10,000阈值下净货币效益为€887(95%CI 324至1450),且在不同结局测量与成本假设下持续为正。

要点

  • PFA组12个月EQ-5D增益0.056(95%CI 0.01至0.10),增量成本为负€328(95%CI 836至180)。
  • PFA相比TKA提供更好且更便宜的结果,即PFA占优TKA。
  • €10,000/QALY阈值下PFA净货币效益为€887(95%CI 324至1450),不同假设下持续为正。

核心结论

  • 在经验丰富的膝关节外科医生操作下,从一年期医院管理视角,PFA治疗孤立性髌股骨关节炎比TKA更便宜且提供更好结局。

研究设计与样本

  • 基于盲法随机临床试验的前瞻性健康结局与资源使用数据,100例孤立性髌股骨关节炎患者随机接受PFA或TKA,由受过两种植入物培训的经验丰富膝关节外科医生手术。

主要发现

  • PFA组12个月EQ-5D增益为0.056(95%CI 0.01至0.10),增量成本为负€328(95%CI 836至180)。
  • PFA因提供更好且更便宜的结果而占优TKA。
  • €10,000阈值下PFA净货币效益为€887(95%CI 324至1450),且在不同结局测量与成本假设下持续为正。

关键数值与推荐

  • 净货币效益计算假设的QALY阈值分别为€10,000、€35,000和€50,000。
  • PFA组12个月EQ-5D增益0.056(95%CI 0.01至0.10),增量成本负€328(95%CI 836至180)。
  • €10,000阈值下净货币效益€887(95%CI 324至1450)。

临床怎么用

  • 对于孤立性髌股骨关节炎,由经验丰富的膝关节外科医生手术时,PFA在一年期医院管理视角下可作为比TKA更具成本效果的选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: The aim is to assess the cost-effectiveness of patellofemoral arthroplasty (PFA) in comparison with total knee arthroplasty (TKA) for the treatment of isolated patellofemoral osteoarthritis (OA) based on prospectively collected data on health outcomes and resource use from a blinded, randomized, clinical trial. METHODS: A total of 100 patients with isolated patellofemoral osteoarthritis were randomized to receive either PFA or TKA by experienced knee surgeons trained in using both implants. Patients completed patient-reported outcomes including EuroQol five-dimension questionnaire (EQ-5D) and 6-Item Short-Form Health Survey questionnaire (SF-6D) before the procedure. The scores were completed again after six weeks, three, six, and nine months, and again after one- and two-year post-surgery and yearly henceforth. Time-weighted outcome measures were constructed. Cost data were obtained from clinical registrations and patient-reported questionnaires. Incremental gain in health outcomes (quality-adjusted life-years (QALYs)) and incremental costs were compared for the two groups of patients. Net monetary benefit was calculated assuming a threshold value of €10,000, €35,000, and €50,000 per QALY and used to test the statistical uncertainty and central assumptions about outcomes and costs. RESULTS: The PFA group had an incremental 12 month EQ-5D gain of 0.056 (95% confidence interval (CI) 0.01 to 0.10) and an incremental 12 month cost of minus €328 (95% CI 836 to 180). PFA therefore dominates TKA by providing better and cheaper outcomes than TKA. The net monetary benefit of PFA was €887 (95% CI 324 to 1450) with the €10,000 threshold, and it was consistently positive when different measures of outcomes and different cost assumptions were used. CONCLUSION: This study provides robust evidence that PFA from a one-year hospital management perspective is cheaper and provides better outcomes than TKA when applied to patients with isolated patellofemoral osteoarthritis and performed by experienced knee surgeons. Cite this article: Bone Joint J 2020;102-B(4):449-457.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Fredborg C, Odgaard A, Sørensen J, et al. Patellofemoral arthroplasty is cheaper and more effective in the short term than total knee arthroplasty for isolated patellofemoral osteoarthritis: cost-effectiveness analysis based on a randomized trial. Bone Joint J. 2020. PMID: 32228074. doi:10.1302/0301-620X.102B4.BJJ-2018-1580.R3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。